Study: Drug manufacturers undermine Rx cost savings tools, increase drug costs
WASHINGTON — A new white paper, “Solving America’s High Drug Cost Problem: Prevent Drug Company Tactics that Increase Costs and Undermine Clinical Quality,” by the Pharmacy Benefit Management Institute (PBMI), released today by the Pharmaceutical Care Management Association (PCMA), outlines ways that some drug manufacturers undermine formulary and utilization management tools, resulting in higher drug costs
